INTERCEPT PHARMACEUTICALS IN's ticker is ICPT and the CUSIP is 45845P108. A total of 180 filers reported holding INTERCEPT PHARMACEUTICALS IN in Q4 2020. The put-call ratio across all filers is 1.51 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $579,567 | +50.7% | 31,262 | -10.1% | 0.02% | +46.7% |
| Q2 2023 | $384,483 | -9.6% | 34,767 | +9.7% | 0.02% | -11.8% |
| Q1 2023 | $425,442 | +8.1% | 31,682 | -0.4% | 0.02% | -15.0% |
| Q4 2022 | $393,440 | -2.4% | 31,806 | +10.1% | 0.02% | -4.8% |
| Q3 2022 | $403,000 | +16.1% | 28,890 | +14.8% | 0.02% | +16.7% |
| Q2 2022 | $347,000 | -18.2% | 25,160 | -3.4% | 0.02% | 0.0% |
| Q1 2022 | $424,000 | +27.3% | 26,033 | +27.2% | 0.02% | +28.6% |
| Q4 2021 | $333,000 | +12.5% | 20,468 | +2.6% | 0.01% | -6.7% |
| Q3 2021 | $296,000 | +8.4% | 19,953 | +45.8% | 0.02% | +7.1% |
| Q2 2021 | $273,000 | +875.0% | 13,686 | +1903.8% | 0.01% | +27.3% |
| Q3 2020 | $28,000 | – | 683 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Chicago Capital Management, LLC | 185,781 | $4,611,565 | 12.16% |
| Samsara BioCapital, LLC | 640,688 | $11,878,356 | 3.64% |
| ALPINE ASSOCIATES MANAGEMENT INC. | 2,203,295 | $40,849,089 | 2.14% |
| Versor Investments LP | 378,480 | $7,017,019 | 1.42% |
| Magnetar Financial LLC | 2,407,209 | $44,629,655 | 1.14% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,077,893 | $38,524,136 | 0.85% |
| Fort Baker Capital Management LP | 430,600 | $7,983,324 | 0.74% |
| EHP Funds Inc. | 84,210 | $1,561,253 | 0.73% |
| Terrapin Asset Management, LLC | 30,000 | $556,200 | 0.63% |
| AQR Arbitrage LLC | 734,970 | $13,626,344 | 0.61% |